MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BCYC made $11,734K in revenue. -$59,208K in net income. Net profit margin of -504.58%.

Income Overview

Revenue
$11,734K
Net Income
-$59,208K
Net Profit Margin
-504.58%
EPS
-$0.85
Unit: Thousand (K) dollars
Revenue Breakdown
    • Genentech
    • Novartis Collaboration Agreement
    • Ionis Collaboration Agreement
    • Bayer

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Collaboration revenue
11,734 2,920 9,977 2,676
Research and development
58,426 71,029 59,058 48,265
General and administrative
18,859 18,493 21,123 18,257
Total operating expenses
77,285 89,522 80,181 66,522
Loss from operations
-65,551 -86,602 -70,204 -63,846
Gain (loss) on extinguishment of debt
----954
Interest and other income
6,700 7,473 8,414 10,583
Interest expense
44 54 51 33
Total other income, net
6,656 7,419 8,363 9,596
Net loss before income tax provision
-58,895 -79,183 -61,841 -54,250
Provision for (benefit from) income taxes
205 -231 -1,087 -3,448
Net loss
-59,100 -78,952 -60,754 -50,802
Foreign currency translation adjustment
-108 -1,902 -1,580 -2,093
Total comprehensive loss
-59,208 -80,854 -62,334 -52,895
Earnings per share, basic
-0.85 -1.14 -0.88 -0.74
Earnings per share, diluted
-0.85 -1.14 -0.88 -0.74
Weighted average number of shares outstanding, basic
69,303,746 69,252,009 69,196,945 68,988,858
Weighted average number of shares outstanding, diluted
69,303,746 69,252,009 69,196,945 68,988,858
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$59,208K Foreign currencytranslation adjustment-$108K Net loss-$59,100K Interest and other income$6,700K Provision for (benefitfrom) income taxes$205K Net loss beforeincome tax provision-$58,895K Total other income,net$6,656K Genentech$6,537K Ionis CollaborationAgreement$2,000K Novartis CollaborationAgreement$2,181K Bayer$1,016K Interest expense$44K Loss from operations-$65,551K Collaboration revenue$11,734K Total operatingexpenses$77,285K General andadministrative$18,859K Research and development$58,426K

BICYCLE THERAPEUTICS PLC (BCYC)

BICYCLE THERAPEUTICS PLC (BCYC)